Brief: Histogen And Amerimmune Enter Into A Collaborative Development And Commercialization Agreement For Emricasan In The Treatment Of Covid-19

Histogen

27/10/2020 12:22

Oct 27 (Reuters) - Histogen Inc  HSTO.O :
    * HISTOGEN AND AMERIMMUNE ENTER INTO A COLLABORATIVE
DEVELOPMENT
AND COMMERCIALIZATION AGREEMENT FOR EMRICASAN IN THE TREATMENT
OF COVID-19
    * HISTOGEN - AMERIMMUNE IS PURSUING NON-DILUTIVE FUNDING IN
ORDER
TO SUPPORT THE CLINICAL PROGRAM

Source text for Eikon:  ID:nGNX44CpSw 
Further company coverage:  HSTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))